The Differential Impact of Donor-Specific Antibodies in Living vs. Deceased Donor Liver Transplantation

被引：0
|
作者：
Levitsky, Josh [1 ]
Tambur, Anat R. [1 ]
Walsh, R. Carlin [1 ]
Jie, Chunfa [1 ]
Kang, Joseph [1 ]
Kaneku, Hugo [2 ]
Abecassis, Michael M. [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
176
引用
收藏
页码：286A / 286A
页数：1
相关论文
共 50 条
  • [21] Outcomes of Pediatric Liver Transplantation: Deceased Donor Liver Transplantation vs Living Donor Liver Transplantation
    Zhang, R.
    Zhu, Z. -J.
    Sun, L. -Y.
    Wei, L.
    Qu, W.
    Zeng, Z. -G.
    Liu, Y.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3601 - 3605
  • [22] Impact of donor-specific antibodies in reconstructive transplantation
    Barone, Angelo A. Leto
    Sun, Zhaoli
    Montgomery, Robert A.
    Lee, W. P. Andrew
    Brandacher, Gerald
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (09) : 835 - 844
  • [23] Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma
    Ogawa, Kohei
    Takada, Yasutsugu
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 1
  • [24] The Influence of Donor-Specific HLA Alloantibodies in Living Donor Liver Transplantation
    Ito, Takashi
    Nakao, Toshimasa
    Harada, Shunpei
    Koshino, Katsuhiro
    Suzuki, Tomoyuki
    Nobori, Shuji
    Ushigome, Hidetaka
    Yoshimura, Norio
    TRANSPLANTATION, 2015, 99 : 296 - 296
  • [25] THE IMPACT OF DONOR-SPECIFIC ANTIBODIES ON THE LONG-TERM LIVER ALLOGRAFT AFTER PEDIATRIC LIVING-DONOR LIVER TRANSPLANTATION.
    Yoshizawa, Atsushi
    Miyagawa-Hayashino, Aya
    Yurugi, Kimiko
    Hishida, Rie
    Yoshitoshi, Elena
    Ogawa, Eri
    Takada, Narito
    Okamoto, Shinya
    Haga, Hironori
    Maekawa, Taira
    Uemoto, Shinji
    PEDIATRIC TRANSPLANTATION, 2013, 17 (03) : 317 - 317
  • [26] Donor-Specific Transfusions vs. Cyclosporine in Living Donor Kidney Transplantation: 30 Year Outcomes.
    Diez, A.
    Von Visger, J.
    Nori, U.
    Pelletier, R.
    Henry, M.
    Pesavento, T.
    TRANSPLANTATION, 2014, 98 : 584 - 584
  • [27] Donor-Specific Transfusions vs. Cyclosporine in Living Donor Kidney Transplantation: 30 Year Outcomes.
    Diez, A.
    Von Visger, J.
    Nori, U.
    Pelletier, R.
    Henry, M.
    Pesavento, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 584 - 584
  • [28] Pharmacokinetics of tacrolimus in live donor liver transplantation (LDLT) vs. deceased donor liver transplantation (DDLT).
    Jain, Ashokkumar
    Venkataramanan, Raman
    Orloff, Mark
    Abt, Peter
    Bozorgzadeh, Adel
    LIVER TRANSPLANTATION, 2007, 13 (06) : S112 - S113
  • [29] Living donor vs. deceased donor liver transplantation for patients with hepatitis C virus-related diseases
    Hu, Anbin
    Liang, Wenhua
    Zheng, Zheng
    Guo, Zhiyong
    He, Xiaoshun
    JOURNAL OF HEPATOLOGY, 2012, 57 (06) : 1228 - 1243
  • [30] Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation
    Terrault, Norah A.
    Shiffman, Mitchell L.
    Lok, Anna S. F.
    Saab, Sammy
    Tong, Lan
    Brown, Robert S., Jr.
    Everson, Gregory T.
    Reddy, K. Rajender
    Fair, Jeffrey H.
    Kulik, Laura M.
    Pruett, Timothy L.
    Seeff, Leonard B.
    LIVER TRANSPLANTATION, 2007, 13 (01) : 122 - 129
12345